Report shows U.S. cancer deaths on the decline
the ONA take:
According to a new report published in the Journal of the National Cancer Institute, there has been a continuing decline in cancer deaths in the United States between 2002 and 2011. During that period, the overall cancer death rate fell an average 1.5% per year for men, women, and children. Specifically, cancer death decreased 1.8% per year among men, 1.4% per year among women, and about 2% per year for children.
The report also found that the rate of new cancer cases also decreased an average 0.5% per year during those years. However, the report found that cancer rates are increasing for kidney, liver, mouth and throat, and thyroid cancer.
"These numbers reflect a combination of factors that include prevention, early detection and improved treatment," said report co-author Ahmedin Jemal, vice president of surveillance research for the American Cancer Society.
Colon and breast cancer deaths are declining due to prevention efforts, while lower rates of lung cancer deaths are due to fewer people smoking. Prostate cancer rates are also declining, but experts are not sure why.
There has been a continuing decline in cancer deaths in the United States between 2002 and 2011.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|